These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 38033847)
1. Expression and Prognostic Value of m6A RNA Methylation-Related Genes in Thyroid Cancer. Han H; Fu X; Zhang Y; Luo D; Zhang X; Wu X Iran J Public Health; 2023 Sep; 52(9):1902-1916. PubMed ID: 38033847 [TBL] [Abstract][Full Text] [Related]
2. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma. Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544 [TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X Front Genet; 2022; 13():872186. PubMed ID: 35937991 [No Abstract] [Full Text] [Related]
4. Correlations of m Li X; Ding Z; Tong Y Int J Gen Med; 2024; 17():775-790. PubMed ID: 38476625 [TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway-Related Prognostic Prediction Model in Gastric Cancer. Jiang F; Chen X; Shen Y; Shen X Front Genet; 2022; 13():891744. PubMed ID: 35928449 [No Abstract] [Full Text] [Related]
6. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment. Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861 [TBL] [Abstract][Full Text] [Related]
7. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer. Jiao J; Jiang L; Luo Y Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363 [TBL] [Abstract][Full Text] [Related]
8. Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation. Zhou W; Lin J; Liu J; Zhang R; Fan A; Xie Q; Hong L; Fan D Aging (Albany NY); 2023 Feb; 15(3):846-865. PubMed ID: 36791151 [TBL] [Abstract][Full Text] [Related]
9. Transcriptome-Wide High-Throughput m6A Sequencing of Differential m6A Methylation Patterns in the Human Rheumatoid Arthritis Fibroblast-Like Synoviocytes Cell Line MH7A. Jiang H; Cao K; Fan C; Cui X; Ma Y; Liu J J Inflamm Res; 2021; 14():575-586. PubMed ID: 33658830 [TBL] [Abstract][Full Text] [Related]
10. [Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia]. Wen Y; Fang S; Yang J; Wang H; Jiao Y; Wang N; Wei Y; Wang L; Dou L Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):690-697. PubMed ID: 35673912 [TBL] [Abstract][Full Text] [Related]
11. m6A methylation in myocardial tissue of septic mice analyzed using MeRIP/m6A-sequencing and RNA-sequencing. Liang X; Hu X; Li J; Zhang B; Gu T; Wang H; Zhang M; Xia X; Guan S; Shangguan W; Miao S; Wang W; Zhang H; Zhao Z; Wang L Funct Integr Genomics; 2024 Sep; 24(5):173. PubMed ID: 39320434 [TBL] [Abstract][Full Text] [Related]
12. Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma. Weng C; Wang L; Liu G; Guan M; Lu L Front Oncol; 2021; 11():763027. PubMed ID: 34868980 [TBL] [Abstract][Full Text] [Related]
13. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma. Qi LW; Jia JH; Jiang CH; Hu JM Front Genet; 2020; 11():614566. PubMed ID: 33519919 [TBL] [Abstract][Full Text] [Related]
14. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma. Sun Z; Jing C; Xiao C; Li T; Wang Y Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247 [TBL] [Abstract][Full Text] [Related]
15. Characterization of ligamentum flavum hypertrophy based on m6A RNA methylation modification and the immune microenvironment. He Z; Zhu Z; Tang T; Guo P; Gao M; Li B; Nguyen TCT; Chen H; Liu X; Zhou Z; Liu S Am J Transl Res; 2022; 14(12):8800-8827. PubMed ID: 36628248 [TBL] [Abstract][Full Text] [Related]
16. Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma. Lin G; Wang H; Wu Y; Wang K; Li G Front Mol Biosci; 2021; 8():682471. PubMed ID: 34295922 [No Abstract] [Full Text] [Related]
17. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
18. Microarray analysis of genes with differential expression of m6A methylation in lung cancer. Wu S; Lv X; Zhang Y; Xu X; Zhao F; Zhang Y; Chen L; Ou-Yang H; Ti X Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34308964 [TBL] [Abstract][Full Text] [Related]
19. The m6A methylation profiles of immune cells in type 1 diabetes mellitus. Wang Y; Xu L; Luo S; Sun X; Li J; Pang H; Zhou J; Zhou Y; Shi X; Li X; Huang G; Xie Z; Zhou Z Front Immunol; 2022; 13():1030728. PubMed ID: 36457997 [TBL] [Abstract][Full Text] [Related]
20. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor. Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]